PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus erythematosus |
| Symptom | C0040053|thrombosis |
| Sentences | 9 |
| PubMedID- 23676348 | Introduction: predicting thrombosis in patients with systemic lupus erythematosus (sle) and/or antiphospholipid antibodies (apl) is still challenging. |
| PubMedID- 25661833 | Subarachnoid hemorrhage and dural sinus thrombosis are important manifestations of neuropsychiatric lupus erythematosus. |
| PubMedID- 25832953 | Cerebral venous thrombosis as a complication of neuropsychiatric systemic lupus erythematosus. |
| PubMedID- 26090493 | Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single-centre experience in china. |
| PubMedID- 22193216 | Reevaluation of predictive value of acl and anti-beta2gp1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world. |
| PubMedID- 25008944 | Previous thrombosis, diagnosis of systemic lupus erythematosus (sle) and triple antiphospholipid (apl) antibody positivity have recently been found to be independent factors associated to pregnancy failure during conventional therapy in women with antiphospholipid syndrome (aps). |
| PubMedID- 25117655 | We investigated the relationship between tpo and the occurrence of thrombocytopenia and thrombosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 22859353 | Hydroxychloroquine (hcq) has been shown in retrospective studies to decrease apl titers in laboratory studies, and to decrease thrombosis risk in patients with systemic lupus erythematosus (sle). |
| PubMedID- 26075289 | In particular, apl positivity has been identified as one of the main determinants of thrombosis among subjects with systemic lupus erythematosus (sle) . |
Page: 1